www.EXFILE.com 888.775-4789 BOSTON SCIENTIFIC CORPORATION -- FORM 8K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 
 
FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of Report (Date of earliest event reported):     September 5, 2007

 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)

DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
    

One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

Registrant’s telephone number, including area code:  (508) 650-8000
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
ITEM 5.02.
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
 
On September 5, 2007, the Board of Directors of Boston Scientific Corporation elected J. Raymond Elliott to the Board of Directors of the Corporation.  Mr. Elliott is the Chairman of Zimmer Holdings, Inc.  He has not yet been appointed to any Board committee.  In connection with his election, he will receive our standard annual director compensation, consisting of an annual cash retainer of $60,000 (pro rated from his election date) and an annual restricted stock grant equal to a number of shares of restricted stock determined by dividing $120,000 by the fair market value of our common stock on September 5, 2007, the date of grant.  Mr. Elliott will be up for election by our stockholders at our May 2008 Annual Stockholders Meeting.
 
The press release is attached hereto as Exhibit 99.1
 
 
 
 
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
 
Exhibit No.
Description
   
99.1
Press Release issued by Boston Scientific Corporation dated September 6, 2007
 
 
 
 
 
 
 
SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
     
  BOSTON SCIENTIFIC CORPORATION
 
 		  
 		  
 
Date:       September 6, 2007 By:   /s/ Lawrence J. Knopf
 
Lawrence J. Knopf
 
Vice President and Assistant General Counsel
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

EXHIBIT INDEX
 

 
Exhibit No.
Description
 
   
99.1
Press Release issued by Boston Scientific Corporation dated September 6, 2007